Developmental Aspects of Long QT Syndrome Type 3 and Brugada Syndrome on the Basis of a Single SCN5A Mutation in Childhood
Overview
Authors
Affiliations
Objectives: The aim was to investigate at what age electrocardiographic characteristics of long QT syndrome type 3 (LQT3) and Brugada syndrome (BS), based on a single SNC5A mutation, appear.
Background: The QT interval (QT) in LQT3 is prolonged during bradycardia. It is not clear yet if this is obvious in young children with a relative fast heart rate (HR).
Methods: Thirty-six children with an SNC5A gene mutation (1795insD) and 46 non-carrier siblings were investigated. In different age groups, HR, QT, QTc, and ST-segment elevation on a 12-lead electrocardiogram (ECG), and HR, QT, QTc, and DeltaQT after the longest pause in a Holter (recording) were evaluated.
Results: In all age groups, HR at rest tended to be lower in carriers than in non-carriers, and QT was longer in carriers than in non-carriers. The Brugada phenotype was found >5 years. Gender specific differences were not identified. The QT at lower HR and DeltaQT were longer in carriers than in non-carriers. A QTc of > or =0.44 s at the lowest HR (sensitivity 100%; specificity 88.4%) and DeltaQT > or =60 ms (sensitivity 100%; specificity 82.6%) were good predictors for having LQT3.
Conclusions: We conclude that electrocardiographic characteristics of LQT3 and BS show age-dependent penetrance. A QT prolongation and conduction disease were present from birth onwards, whereas ST-segment elevation only developed >5 years. Good tools for clinical diagnosis of LQT3 in this family are QTc at the lowest HR and DeltaQT after a pause in a Holter, even at very young age.
Antiseizure medication and SUDEP - a need for unifying methodology in research.
Aurlien D, Tauboll E Front Neurol. 2024; 15:1385468.
PMID: 38694773 PMC: 11061368. DOI: 10.3389/fneur.2024.1385468.
SCN5A-1795insD founder variant: a unique Dutch experience spanning 7 decades.
Proost V, van den Berg M, Remme C, Wilde A Neth Heart J. 2023; 31(7-8):263-271.
PMID: 37474841 PMC: 10400486. DOI: 10.1007/s12471-023-01799-8.
: A novel class of potential antiarrhythmic compounds.
Abdelsayed M, Page D, Ruben P Front Pharmacol. 2022; 13:976903.
PMID: 36249789 PMC: 9554508. DOI: 10.3389/fphar.2022.976903.
Nowak M, Veeraraghavan R, Poelzing S, Weinberg S Front Physiol. 2021; 12:731025.
PMID: 34759834 PMC: 8573326. DOI: 10.3389/fphys.2021.731025.
Lee S, Wong W, Wong I, Mak C, Mok N, Liu T Front Cardiovasc Med. 2021; 8:671666.
PMID: 34179137 PMC: 8225934. DOI: 10.3389/fcvm.2021.671666.